We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Medical Solutions Enters an Exclusive UK Agreement with Empire Genomics

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

The Board of Medical Solutions plc announce that it will partner with Empire Genomics, Inc. to be the exclusive UK distributor and service provider for its ACCUArray array comparative genomic hybridization (“aCGH”) genotyping technology.

In addition to distributing the product, Medical Solutions will also offer the genotyping service from its laboratories in Nottingham, which will include in-house bioinformatics analysis and support.


• Exclusive distributor and service provider in the UK;

• Medical Solutions to offer both Human and Mouse ACCUArray aCGH as a product and also provide the genotyping service that will include in-house bioinformatic analysis;

• Novel DNA array for pre-natal, cancer and pharmacogenetic testing with diagnostic and research applications;

• Enhanced portfolio of genomic products and services provided in GLP, GCP and CPA accredited laboratories.

The addition of Empire Genomics ACCUArray will complement Medical Solutions existing portfolio of genomic products and contract research services including DNA clones and genomic analyses. The assay has clinical diagnostic applications for the healthcare community and can be used for pharmacogenetic testing by companies in the pharma biotech sector.